Form D · Pharmaceuticals
SATORI PHARMACEUTICALS INC
Cambridge, MA · CIK 0001329516
Offering snapshot reported Feb 23, 2012 · SEC filing
- Reported sold
- $15M Offering amount: $19.2M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2012 | Initial | $15,000,000 | No comparison | 0 | SEC filing |
| Jan 3, 2011 | Initial | $7,000,000 | No comparison | 3 | SEC filing |
| Apr 5, 2010 | Initial | $315,000 | No comparison | 1 | SEC filing |
| Jun 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 6, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-173852
Source: Form D, filed Feb 23, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Ehrlich | Director |
| Chris Ehrlich | Director |
| Steven Holtzman | Director |
| Jeffrey Ives | Director, Executive |
| Edward Mathers | Director |
| Stephen Muniz | Director |
| David Schnell | Director |
| Bennett Shapiro | Director |
| Ilan Zipkin | Director |
| Daphne Zohar | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
281 Albany Street
Cambridge, MA, 02139
Cambridge, MA, 02139